Silgan 3Q 2026: Revenue $2.04B, EPS $0.99 — 10-Q Summary
Less than 1 min read
Third-quarter net sales rose 1.6% year over year, while net income declined. Higher raw-material and manufacturing-cost pass-through and favorable custom-container product mix lifted sales, but lower volumes, less favorable mix in other segments, higher rationalization and corporate-development costs, and weaker dispensing-segment manufacturing efficiency weighed on operating income.
Financial Highlights
| Metric | Current quarter | Prior year quarter | YoY change |
| Revenue¹ | $2.04B | $2.01B | 1.6% |
| Net income² | $104.98M | $113.29M | (7.3%) |
| Diluted EPS³ | $0.99 | $1.06 | (6.6%) |
¹ Reported as “Net sales”. ² Reported as “Net income”. ³ Reported as “Diluted net income per share”.
Business Highlights
- Dispensing and Specialty Closures: Sales rose 1.3%; unit volumes were comparable, with fragrance and pharma dispensing growth offset by softer food and beverage closure demand.
- Metal Containers: Sales increased 1.4% despite unit volumes falling approximately 4%; adjusted EBIT rose as inventory management and manufacturing efficiencies improved.
- Custom Containers: Sales rose 4.2% on cost pass-through and favorable mix, partly offset by volumes down approximately 8%, primarily reflecting exited lower-margin business.
- Outlook: The proposed Trivium acquisition is expected to close mid-2027, subject to regulatory approvals, works council consultations and customary closing conditions.
Original SEC Filing: SILGAN HOLDINGS INC [ SLGN ] - 10-Q - Nov. 05, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.